New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccineThe shot, named mFlusiva, is intended for adults age 50 or olderFlu vaccines must be updated annually to best match circulating strains of the virusBy AP · 6 August 2026
Moderna plans regional expansion in 5 years, top official tell Arab NewsBy Reina Takla · 10 June 2023
SpecialHow new mRNA technologies are advancing the race for a cancer vaccineBy Rawan Radwan · 27 April 2023
